EP1009232A4 - Methods for treating insulin resistance and identifying patients at risk for the disease - Google Patents
Methods for treating insulin resistance and identifying patients at risk for the diseaseInfo
- Publication number
- EP1009232A4 EP1009232A4 EP97953324A EP97953324A EP1009232A4 EP 1009232 A4 EP1009232 A4 EP 1009232A4 EP 97953324 A EP97953324 A EP 97953324A EP 97953324 A EP97953324 A EP 97953324A EP 1009232 A4 EP1009232 A4 EP 1009232A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- disease
- risk
- methods
- insulin resistance
- identifying patients
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 206010022489 Insulin Resistance Diseases 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
- G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Diabetes (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Rheumatology (AREA)
- Cell Biology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Epidemiology (AREA)
- Rehabilitation Therapy (AREA)
- Zoology (AREA)
- Emergency Medicine (AREA)
- Biotechnology (AREA)
- Obesity (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3450496P | 1996-12-24 | 1996-12-24 | |
US34504P | 1996-12-24 | ||
US3741797P | 1997-02-21 | 1997-02-21 | |
US37417P | 1997-02-21 | ||
PCT/US1997/023481 WO1998027813A1 (en) | 1996-12-24 | 1997-12-23 | Methods for treating insulin resistance and identifying patients at risk for the disease |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1009232A1 EP1009232A1 (en) | 2000-06-21 |
EP1009232A4 true EP1009232A4 (en) | 2002-06-12 |
Family
ID=26711037
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP97953324A Withdrawn EP1009232A4 (en) | 1996-12-24 | 1997-12-23 | Methods for treating insulin resistance and identifying patients at risk for the disease |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1009232A4 (en) |
JP (1) | JP2001508770A (en) |
AU (1) | AU5709698A (en) |
CA (1) | CA2276149A1 (en) |
WO (1) | WO1998027813A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20230090336A (en) * | 2020-10-13 | 2023-06-21 | 베타바이브 리미티드 | Methods and compounds for treating diabetes and related metabolic diseases |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8920381D0 (en) * | 1989-09-08 | 1989-10-25 | Greater Glasgow Health Board | Treatment of insulin-resistant diabetes |
-
1997
- 1997-12-23 WO PCT/US1997/023481 patent/WO1998027813A1/en not_active Application Discontinuation
- 1997-12-23 AU AU57096/98A patent/AU5709698A/en not_active Abandoned
- 1997-12-23 CA CA002276149A patent/CA2276149A1/en not_active Abandoned
- 1997-12-23 EP EP97953324A patent/EP1009232A4/en not_active Withdrawn
- 1997-12-23 JP JP52897198A patent/JP2001508770A/en not_active Ceased
Non-Patent Citations (6)
Title |
---|
CHASALOW F I ET AL: "CORRELATION OF IGF-2 CONCENTRATIONS WITH INSULIN REQUIREMENTS IN DIABETES MELLITUS", PEDIATRIC RESEARCH, WILLIAMS AND WILKINS, BALTIMORE, MD,, US, vol. 37, no. 4, PART 2, 1994, pages 86A, XP001024844, ISSN: 0031-3998 * |
FROESCH ER ET AL.: "Insulin-like growth factor-I in the therapy of non-insulin-dependent diabetes mellitus and insulin resistance", DIABETES & METABOLISM (PARIS), vol. 22, 1996, pages 261 - 267, XP001041950 * |
FROST RA ET AL.: "Wasting in the acquired immune deficiency syndrome is linked associated with multiple defects in serum inulin-like growth factor system", CLINICAL ENDOCRINOLOGY, vol. 44, May 1996 (1996-05-01), pages 501 - 514, XP001024899 * |
JOHANSSON JO ET AL.: "Growth hormone deficient adults are insulin-resistant", METABOLISM, vol. 44, no. 9, 1995, pages 1126 - 1129, XP001041622 * |
JUÁREZ-AGUILAR E ET AL.: "22-kDa and 20-kDa isoforms show differential effects when assayed in 3T3-F442A and T3-F442A/C4 adipiocytes", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATION, vol. 217, no. 1, 1995, pages 28 - 33, XP001024865 * |
See also references of WO9827813A1 * |
Also Published As
Publication number | Publication date |
---|---|
WO1998027813A1 (en) | 1998-07-02 |
CA2276149A1 (en) | 1998-07-02 |
AU5709698A (en) | 1998-07-17 |
JP2001508770A (en) | 2001-07-03 |
EP1009232A1 (en) | 2000-06-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL116847A0 (en) | Diagnostic imaging contrast agents and methods for extending the blood retention thereof | |
IL120935A0 (en) | Medical apparatus for facilitating blood circulation in the lower limbs | |
EP0782439A4 (en) | Biocompatible coating, medical device using the same and methods | |
IL125756A (en) | Catheter for use in surgery | |
EP0800795A4 (en) | Medical coagulation apparatus | |
IL139030A0 (en) | Therapeutic angiogenic factors and methods for their use | |
EP1065978A4 (en) | Implantable therapeutic device and method | |
EP1056514A4 (en) | Endoluminal implant with therapeutic and diagnostic capability | |
HK1023832A1 (en) | Clinical and/or surgical training apparatus | |
HK1010498A1 (en) | Oriented medical tubing | |
EG21712A (en) | Treatment of insulin resistance | |
AU3887599A (en) | Medical analysis and treatment method and system | |
GB9425493D0 (en) | Modified cannula | |
ZA987174B (en) | Procedures and materials for conferring disease resistance in plants. | |
EP0987553A4 (en) | Method for identifying cholesterol in the skin tissue | |
ZA97825B (en) | Method and system for identifying at risk patients diagnosed with depression. | |
HK1045269A1 (en) | Blood-related dialysis and treatment | |
EP0921803A4 (en) | Methods for preventing and treating pestivirus infection and associated diseases | |
GB9606076D0 (en) | Diabetes treatment | |
EP1009232A4 (en) | Methods for treating insulin resistance and identifying patients at risk for the disease | |
ZA976547B (en) | Lipid-binding proteins and their therapeutic and diagnostic use | |
GB9421223D0 (en) | Tissue imaging in gene therapy | |
GB9617550D0 (en) | Medical ice-pack | |
GB2310804B (en) | Modified cannula | |
AU3159297A (en) | Device for treating the human body with heat |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19990727 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: SUPERGEN, INC. |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20020503 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
RIC1 | Information provided on ipc code assigned before grant |
Free format text: 7A 01N 37/18 A, 7A 61K 38/00 B, 7A 61K 38/28 B, 7A 61K 38/27 B |
|
17Q | First examination report despatched |
Effective date: 20021120 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20030401 |